STUBBS S-Onco: Product Profile

STUBBS S-Onco is a named branded product for Dogs and cats of all breeds and ages according to the manufacturer; manufacturer positioning must be kept separate from independent clinical evidence.

Oral powder in a 90 g jar. Intended species: Dogs and cats of all breeds and ages according to the manufacturer.

Cordyceps sinensis; Ganoderma lucidum; Curcuma longa; Moringa oleifera; Centella asiatica; Camellia sinensis; Withania somnifera; magnesium; and zinc. The public manufacturer page reviewed names ingredients but does not provide all quantitative amounts.

STUBBS markets S-Onco for immune-system support in oncological situations. The official page attributes apoptosis, antiproliferative, antioxidant, cytotoxic, angiogenesis, immune, and cachexia-related mechanisms to individual ingredients. Those statements are manufacturer rationale and do not establish a clinical outcome for the finished powder.

May be discussed only as adjunctive/supportive care within a veterinarian-led plan; it must not replace diagnosis, staging, standard treatment, symptom control, or emergency care.

Define a modest supportive goal, objective review date, adverse-effect plan, and stopping rule with the veterinarian.

Bring the current label, lot, complete ingredient panel, seller and country version, and every medicine and supplement to the treating veterinarian.

No controlled canine or feline oncology trial of the complete S-Onco formulation was identified in the official sources reviewed. Preclinical findings about an ingredient, mushroom, or plant cannot establish that the combination shrinks tumors, delays progression, improves treatment response, or extends survival. The manufacturer page is a primary source for label identity, not independent efficacy evidence.

The multi-ingredient formula warrants review for mushroom allergy, gastrointestinal effects, sedation or stimulation, thyroid or endocrine disease, liver metabolism, blood pressure, bleeding, anticoagulants, immunosuppressants, surgery, pregnancy, and duplicate magnesium or zinc. Green tea, turmeric, ashwagandha, mushrooms, and minerals can each matter in a complex plan.

No universal compatibility conclusion is made. Review the complete label and individualized treatment plan with the veterinarian.

Marketed in Portugal as a feed/supplement for dogs and cats. No EU veterinary-medicine marketing authorization for cancer treatment was identified. The product should be described as complementary nutritional support rather than a licensed antineoplastic medicine.

Portugal; European Union

Record the Portuguese/EU package, lot, full label, start date, and supportive goal. Monitor appetite, vomiting, diarrhea, stool, activity, sleep or behavior change, skin reactions, bruising, and body weight. Maintain treatment-specific examinations, laboratory tests, imaging, and response assessment. Review benefit and tolerance at a defined date rather than continuing automatically.